ArticleOncoTargets and therapy2020

Pathological Complete Response from Pyrotinib Combined with Trastuzumab, Paclitaxel and Cisplatin in a Postpartum Woman with HER2-Positive Locally Advanced Breast Cancer: A Case Report.

Lina He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.